Eris Lifesciences Limited (NSE: ERIS)
India
· Delayed Price · Currency is INR 1,423.10
+53.15 (3.88%)
Oct 9, 2024, 3:30 PM IST
Eris Lifesciences Revenue
Eris Lifesciences had revenue of 7.16B INR in the quarter ending June 30, 2024, with 55.55% growth. This brings the company's revenue in the last twelve months to 22.47B, up 29.89% year-over-year. In the fiscal year ending March 31, 2024, Eris Lifesciences had annual revenue of 19.91B with 19.83% growth.
Revenue (ttm)
22.47B
Revenue Growth
+29.89%
P/S Ratio
8.45
Revenue / Employee
6.21M
Employees
3,620
Market Cap
189.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 19.91B | 3.29B | 19.83% |
| Mar 31, 2023 | 16.62B | 3.36B | 25.31% |
| Mar 31, 2022 | 13.26B | 1.34B | 11.20% |
| Mar 31, 2021 | 11.93B | 1.34B | 12.71% |
| Mar 31, 2020 | 10.58B | 909.81M | 9.41% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEris Lifesciences News
- 7 days ago - Market movers: BSE rises 6.90%, JP Power up 4.96%, JSW Steel gains 1.98%, Jindal Steel climbs 2.43%, Eris Lifesciences up 3.56%, Just Dial adds 2.53% among key gainers - Business Upturn
- 7 days ago - Eris Lifesciences stock up 3.24%, sees ₹270.76 crore block deal as 2 million shares change hands - Business Upturn
- 7 weeks ago - ChrysCapital sells entire stake in Eris Lifesciences for ₹1,187 Crore - Business Upturn
- 7 weeks ago - Eris Lifesciences sees 7.2% equity change hands in ₹1,187 crore block deal - Business Upturn